The CM compound (JPYZXZ) effectively remodels the immunosuppressive TME by inhibiting the exosomal PD‐L1‐mediated amplification of MDSCs, thereby mitigating GC progression [18]. The gene discussed is CD274; the disease is gastric cancer.